Tussin Dm Liquid
Product Images NDC 53942-503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tussin Dm (NDC 53942-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Demoulas Market Basket, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aptapharmmb Tussin Dm (Aptapharmmb Tussin Dm 503)

Aptapharmmb Tussin Dm (Aptapharmmb Tussin Dm 503)
This text seems to be describing two different cough and chest congestion medicines: Tussin DM and "Cough & Chest," both of which come in an 8FL OZ bottle. The text also mentions expectorants as a potential ingredient. Otherwise, there is little context or additional information.*
FDA Label Image

Aptapharmmb Tussin Dm 1 (Aptapharmmb Tussindm 503 1)

Aptapharmmb Tussin Dm 1 (Aptapharmmb Tussindm 503 1)
This is a drug facts label of a cough suppressant and expectorant medication listing its active ingredients, uses, warnings, and directions. The active ingredients of each 5 mL teaspoonful are 10 mg Dextromethorphan HBr for cough suppression and 100 mg Guaitenesin for phlegm and bronchial secretion relief. The product is suitable for temporary relief of cough caused by minor throat and bronchial irritation due to a cold and to loosen phlegm to drain the bronchial tubes. The label warns not to administer to children under 12 years of age, and to seek medical advice before use by pregnant or breastfeeding women, and by anyone currently taking prescription drugs. More importantly, the product must be discontinued and a doctor consulted if cough lasts more than a week, comes back, or is accompanied by fever, rash, or headache, as these may indicate a serious condition. The direction restricts the product to not more than six doses every 24 hours. Finally, the label has other important information about storing the product, the dosage cup provided, the full labeling instructions on the carton, inactive ingredients, and distribution information.*
FDA Label Image

Aptapharma Tussindm2 Label (Aptapharmamb Tussindm2)

Aptapharma Tussindm2 Label (Aptapharmamb Tussindm2)
This text provides dosage instructions for a certain medication. It recommends that adults and children over the age of 12 take 2 teaspoonfuls every 4 hours, while children under 12 should not use the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.